Gilead's CEO is leaving by the end of the year, and the biotech giant still hasn't picked a replacement. Wall Street has a few ideas.

This is a Business Insider Prime story. Click the link below to read it.

Read Full story

Add Comment()
Comments ()
Sort By:
Be the first one to comment.
We have sent you a verification email. This comment will be published once verification is done.